The abstract is read at the publisher; the summary is JClub's.
Metastatic dormancy is linked to a dynamic immune–tumor equilibrium where disseminated tumor cells persist for years before relapse by evading immune elimination through multiple mechanisms.
- Why it matters: Dormant disseminated cells can survive long enough to seed relapse, and inflammatory stress during tissue remodeling may weaken immune restraint and enable metastatic outgrowth.
- What they did: The review synthesizes evidence that immune evasion involves spatial/numerical rarity, insufficient immune effectors, suppressed innate immune signaling and inflammasome pathways, and adaptation to local immune niches, highlighting emerging single-cell and spatial profiling in patients.
- The result: Defining dormant disseminated tumor cell states and niches in patients could enable strategies to eradicate minimal residual disease, restore immune surveillance, and prevent inflammatory reawakening.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.